DelveInsight’s Chronic Refractory Cough Market Insights report includes a comprehensive understanding of current treatment practices, emerging chronic refractory cough drugs, market share of ...

Please provide your email address to receive an email when new articles are posted on . These results, published in JAMA in conjunction with a presentation at the European Respiratory Society ...

Expect to enroll 60 subjects across a broad range of cough frequencies RIVER topline data expected in the second half of 2024 NEW HAVEN, Conn., Nov. 2, 2023 /PRNewswire/ -- Trevi Therapeutics, Inc.

Smoking cannabis may increase the risk of respiratory disease such as chronic bronchitis, but quitting is likely to reduce the symptoms. It is unknown at this time whether cannabis use is linked to ...

MANCHESTER, England & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Axalbion, a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough, today announced positive ...

Chronic cough, defined as a cough lasting at least 8 weeks, affects approximately 5% of the European population, particularly older adults and individuals with a history of smoking. In some cases, ...

Topline results are expected in the first quarter of 2025 NEW HAVEN, Conn., Oct. 21, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (TRVI) (Nasdaq: TRVI), a clinical-stage biopharmaceutical company ...

Pharma giant GlaxoSmithKline on Tuesday announced a deal to buy Canadian biotech Bellus Health for $2 billion, betting big on the firm’s cough medicine as it moves to shore up its slender drug ...

(RTTNews) - Drug major Merck & Co., Inc. (MRK) announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP, has recommended the approval of ...

Please provide your email address to receive an email when new articles are posted on . The Healio Editors compiled the most-read chronic cough news published in 2021. Highlights from the previous ...

DelveInsight’s Chronic Refractory Cough Market Insightsreport includes a comprehensive understanding of current treatment practices, emerging chronic refractory cough drugs, market share of individual ...